Prosecution Insights
Last updated: October 01, 2026

Examiner: RODJOM, KATHERINE MARIE

Tech Center 3700 • Art Units: 3731 3734 3771 3773 3786

This examiner grants 65% of resolved cases

Analysis

Katherine Marie Rodjom is an examiner in Tech Center 3700, specifically Art Unit 3731. With a large volume of 670 resolved cases, the examiner has an allowance rate of 65.4 percent. This rate suggests a favorable environment for applicants, with a majority of cases resulting in a patent grant. The 65.4 percent allowance rate, based on 670 cases, provides a high degree of statistical reliability for practitioners planning their prosecution strategy.

The interview lift is 34.5 percent, demonstrating that interviews are a productive tool for advancing applications. This lift indicates that cases involving an interview have a significantly higher probability of allowance than those that do not. For practitioners in Tech Center 3700, the 34.5 percent lift underscores the importance of scheduling interviews to address examiner concerns and reach a consensus on patentable subject matter.

The median days to allowance is 1572. This is a relatively long duration, indicating that while the probability of allowance is high, the process takes a significant amount of time. Applicants should be prepared for a prosecution cycle of 1572 days when working with this examiner. This timeline is a critical factor for businesses to consider when aligning their patent strategy with product launch cycles or other commercial milestones in Art Unit 3731.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

65.4%
Allow Rate
-4.6% vs TC avg
697
Total Applications
+34.5%
Interview Lift
1572
Avg Prosecution Days
Based on 670 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
23.9%
§102 Novelty
47.9%
§103 Obviousness
18.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18489491 OCCLUSIVE MEDICAL DEVICE WITH FIXATION MEMBERS Non-Final OA BOSTON SCIENTIFIC SCIMED, INC.
18807092 METHOD OF SUTURING A TROCAR PATH INCISION Non-Final OA Cilag GmbH International
17507500 VASCULAR ACCESS Final Rejection ABIOMED EUROPE GMBH
18238570 VASCULAR IMPLANT Final Rejection KFNT Holdings, LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month